Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
Mahmoud E. Youssef, Galal Yahya, Mihaela Simona Popoviciu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6039-6039
Open Access | Times Cited: 36
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Lobna A. Saleh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1123-1123
Open Access | Times Cited: 30
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113409-113409
Closed Access | Times Cited: 35
Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112723-112723
Open Access | Times Cited: 29
Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
Osama A. Mohammed, Ahmed S. Doghish, Lobna A. Saleh, et al.
Pathology - Research and Practice (2024) Vol. 253, pp. 155086-155086
Closed Access | Times Cited: 5
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
Noha F. Abdelkader, Marawan A. Elbaset, Passant E. Moustafa, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 7, pp. 475-493
Open Access | Times Cited: 24
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
A. M. Abdelhamid, Mahmoud E. Youssef, Simona Cavalu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
Eslam E. Abd El-Fattah, Amr Y. Zakaria
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114553-114553
Open Access | Times Cited: 13
Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis
Ahmed S. Saad, Rachel Michel, Mostafa A. Borahay
Current Nutrition Reports (2024) Vol. 13, Iss. 3, pp. 557-565
Closed Access | Times Cited: 4
The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders
Simona Cavalu, Sameh Saber, Ahmed E. Amer, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 4
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
Life Sciences (2024) Vol. 354, pp. 122966-122966
Open Access | Times Cited: 4
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs
Sameh Saber, Mohamed Nasr, Mohamed M.Y. Kaddah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112731-112731
Open Access | Times Cited: 18
Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Eslam E. Abd El-Fattah, Amr Y. Zakaria
International Immunopharmacology (2022) Vol. 109, pp. 108889-108889
Closed Access | Times Cited: 18
Linagliptin, a DPP‐4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
Rasha Abdelhady, Osama A. Mohammed, Ahmed S. Doghish, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 3
Sotagliflozin attenuates liver associated disorders in cystic fibrosis rabbits
Xiubin Liang, Xia Hou, Mohamad Bouhamdan, et al.
JCI Insight (2024)
Open Access | Times Cited: 3
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis
Mona H. Zohny, Mohammed Alrouji, Sharif Alhajlah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113651-113651
Open Access | Times Cited: 15
Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways
Panpan Chen, Rong Wang, Fangbin Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Integrated network analysis and metabolomics reveal the molecular mechanism of Yinchen Sini decoction in CCl4-induced acute liver injury
Weiwei Zheng, Chao Shi, Yao Meng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A. Mohammed, Mahmoud E. Youssef, Ahmed S. Doghish, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 198, pp. 106792-106792
Open Access | Times Cited: 2
BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis
Sameh Saber, Mohannad Mohammad S. Alamri, Jaber Alfaifi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 953-953
Open Access | Times Cited: 6
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives
Osama A. Mohammed, Sameh Saber, Mustafa Ahmed Abdel‐Reheim, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116943-116943
Closed Access | Times Cited: 1
Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 200, pp. 106849-106849
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top